Evidence map›Paper›PMID 39068921›Full record

ArticleIntervirology2024

Nanoparticles with a Lipid Core Can Enhance the Infection of Epithelial Cells with an Enterovirus.

Inès Vergez, Magloire Pandoua Nekoua, Cédric Rubrecht, François Fasquelle, Angelo Scuotto, Enagnon Kazali Alidjinou, Didier Betbeder, Didier Hober

Abstract readNews
In one paragraph

Article in Intervirology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Inès VergezUniv. Lille, CHU Lille, Laboratoire de Virologie URL3610, Lille, France.
Magloire Pandoua NekouaUniv. Lille, CHU Lille, Laboratoire de Virologie URL3610, Lille, France.
Cédric RubrechtUniv. Lille, CHU Lille, Laboratoire de Virologie URL3610, Lille, France.
François FasquelleVaxinano SAS, Loos, France.
Angelo ScuottoVaxinano SAS, Loos, France.
Enagnon Kazali AlidjinouUniv. Lille, CHU Lille, Laboratoire de Virologie URL3610, Lille, France.
Didier BetbederVaxinano SAS, Loos, France.
Didier HoberUniv. Lille, CHU Lille, Laboratoire de Virologie URL3610, Lille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe effect of maltodextrin-based nanoparticles with an anionic phospholipid core (lipid-based nanoparticles [NPLs]) on the infection of a human tumoral cell line with poliovirus (PV) has been studied.

methodsNPLs were synthesized and associated with the PV type 1 Sabin strain, and the formulations were characterized. PV and PV/NPL formulations were inoculated to HEp-2 cells.

resultsThe surface charge and the diameter of PV/NPL formulation suggest that viral particles were adsorbed onto NPLs. When HEp-2 cells were inoculated with 1 tissue culture 50% infectious dose/mL PV associated with NPLs, the cytopathic effect appeared obvious; the levels of the infectious titer of culture supernatants and the proportion of VP1-positive cells were higher. The level of intracellular viral RNA extracted from HEp-2 cells inoculated with PV/NPL formulation was higher as well.

conclusionThese results show that NPLs can enhance the infection with a virus and suggest that they might be used in virotherapy to increase the virus-mediated lysis of tumor cells.

Indexed as

Epithelial CellsNanoparticlesPoliovirusCell Line, TumorCytopathogenic Effect, ViralHumansLipidsLiposomesPolysaccharidesRNA, ViralLipid NanoparticlesLipidsLiposomesPolysaccharidesRNA, ViralEnterovirusInfectionIn vitroNanoparticlesTumor cell line

Identifiers

PMID39068921
PMCPMC11524536

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.